Background:  Relax-Cardio is a multicenter, randomized, double-blind, crossover placebo-controlled Phase II study to assess the effect of serelaxin versus placebo on high-sensitivity cardiac troponin I (hs-cTnI) release in patients with chronic heart failure after exercise when used in addition to standard of care. Trial Registration No: NCT02625922 (clinicaltrials.gov) Link  Trial Status: Randomized worldwide: 16 (of N=120)  Randomized in Basel: 3 (of N=10) Enrolling Centers:  Switzerland Worldwide: University Hospital Basel  4 in Germany  4 in UK  Core Study Team: 
Home News Team Current Studies Publications Events Cooperations Contact
© Christian Mueller, 2012 - 2017  │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: June 2017
Dr. Beate Hartmann Dr. Samyut Shrestha Kristin Podkowik Alexandra Richterich-Jenal